Results 21 to 30 of about 2,196,135 (231)

Drug-Coated Balloon vs. Drug-Eluting Stent in Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis

Anatolian Journal of Cardiology, 2023
Background: This study aimed to systematically review the evidence of drug-coated balloon used in the treatment of acute myocardial infarction and compared with using drug-eluting stent in terms of clinical and angiographic outcomes for a relatively long
Zhen Fang, Jun Ji, Shenghu He, Ning Liu, Bing Xu   +4 more
doaj   +1 more source

Comparison of Primary Patency Rate between Drug- Coated Balloon and Plain Balloon Angioplasty in Hemodialysis Access

Siriraj Medical Journal, 2022
Objective: Hemodialysis adequacy in end-stage renal disease patients plays a crucial role in their quality of life. Repeated stenosis at the anastomotic site of arteriovenous fistula and synthetic arteriovenous graft are a major cause of access failure ...
Trakarn Chaivanit, Pechngam Chaivanit, Pakpume Bumrungrachapukdee, Pongtrip Unprasert, Krittanont Wattanavaekin, Thoetphum Benyakorn   +5 more
doaj   +1 more source

Head-to-head comparison of sirolimus- versus paclitaxel-coated balloon angioplasty in the femoropopliteal artery: study protocol for the randomized controlled SIRONA trial

Trials, 2021
Background Endovascular revascularization has established as the first-line therapy of femoropopliteal artery disease. Paclitaxel-coated balloon angioplasty proved to be superior to plain old balloon angioplasty (POBA) regarding prevention of restenosis ...
Ulf Teichgräber, Maja Ingwersen, Stephanie Platzer, Thomas Lehmann, Thomas Zeller, René Aschenbach, Dierk Scheinert   +6 more
doaj   +1 more source

A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions.

PLoS ONE, 2021
BackgroundDrug coated balloons (DCB) with paclitaxel (Ptx) dose of 2-3.5 μg/mm2 balloon surface inhibit restenosis with different effectiveness and duration of success. A clinical dose finding study is not known for any of the currently marketed products.
Ole Gemeinhardt, Beatrix Schnorr, Ulrich Speck, Bruno Scheller   +3 more
doaj   +2 more sources

Structural and temporal dynamics analysis on drug-eluting stents: History, research hotspots and emerging trends

Bioactive Materials, 2023
Purpose: This review aims to explore the history, research hotspots, and emerging trends of drug-eluting stents(DES)in the last two decades from the perspective of structural and temporal dynamics.
Lili Tan, Xiangxiu Wang, Kungshan Yuan, Tieying Yin, Ruolin Du, Li Shen, Zhirong Zhu, Suhua Yu, Haijun Zhang, Guixue Wang   +9 more
doaj   +1 more source

Sustained drug retention after paclitaxel-coated balloon angioplasty for superficial femoral artery disease: Follow-up intravascular imaging

SAGE Open Medical Case Reports, 2020
A 63 year-old woman with claudication underwent endovascular therapy for diffuse stenosis of the right superficial femoral artery in our hospital. We performed paclitaxel-coated balloon angioplasty using the IN.PACT™ Admiral™ and achieved acceptable ...
Norihiro Kobayashi, Keisuke Hirano, Masahiro Yamawaki, Motoharu Araki, Tsuyoshi Sakai, Yasunari Sakamoto, Shinsuke Mori, Masakazu Tsutsumi, Masahiro Nauchi, Naohiko Sahara, Yohsuke Honda, Kenji Makino, Shigemitsu Shirai, Masafumi Mizusawa, Yuta Sugizaki, Takahide Nakano, Tomoya Fukagawa, Toshihiko Kishida, Yuki Kozai, Yusuke Setonaga, Shutaro Goda, Yoshiaki Ito   +21 more
doaj   +1 more source

Debate. Drug-coated balloons for de novo coronary artery lesions. Evidence available and potential superiority in some settings

REC: Interventional Cardiology (English Ed.), 2023
QUESTION: What is the evidence available on the use of drug-coated balloons (DCB) in the de novo lesion setting? ANSWER: The use of DCB to treat de novo lesions is the most compelling argument regarding this technology, an area that has advanced ...
Bernardo Cortese
doaj   +1 more source

Time course of vascular response after an a priori strategy of bare metal stent implantation post-dilated with a paclitaxel-coated balloon: Implementation of a three-dimensional analysis algorithm with optical coherence tomography [PDF]

, 2016
Background: An a priori combined therapy of a bare metal stent post-dilated with a paclitaxel- -coated balloon (PCB) was investigated with optical coherence tomography (OCT) at 2 and 6 months regarding vessel response.
Gassdorf, Johannes; University Clinic of Jena, 1st Medical Dept., Division of Cardiology, Erlanger Allee 101, 07740 Jena, Poerner, Tudor C.; University Clinic of Jena, 1st Medical Dept., Division of Cardiology, Erlanger Allee 101, 07740 Jena, Otto, Sylvia; 1st Clinic of Medicine, Division of Cardiology, University Hospital of Jena, Germany, Kryvanos, Aleh; UltraOsteon, Mannheim, Nitsche, Kristina; University Clinic of Jena, 1st Medical Dept., Division of Cardiology, Erlanger Allee 101, 07740 Jena, Figulla, Hans R.; University Clinic of Jena, 1st Medical Dept., Division of Cardiology, Erlanger Allee 101, 07740 Jena, Gutiérrez-Chico, Juan Luis; Dept. of Interventional Cardiology, Klinikum Frankfurt /Oder, Goebel, Björn; University Clinic of Jena, 1st Medical Dept., Division of Cardiology, Erlanger Allee 101, 07740 Jena   +7 more
core   +1 more source

Study on the safety and effectiveness of drug-coated balloons in patients with acute myocardial infarction

Journal of Cardiothoracic Surgery, 2021
background Drug-coated balloon (DCB) is a new technology that has emerged in recent years and has been proven to be effective and safe in the treatment of in-stent restenosis. The purpose of this article is to observe the safety and effectiveness of drug-
Little teacher is good, Damien Yellow, Asaka King, Jin Chun Zhang, Li Hongqiang Liu, Yingmin road   +5 more
doaj   +1 more source

Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese Association of Cardiovascular Intervention and Therapeutics

Cardiovascular Intervention and Therapeutics, 2023
Drug-coated balloon (DCB) technology was developed to deliver the antiproliferative drugs to the vessel wall without leaving any permanent prosthesis or durable polymers.
T. Muramatsu, K. Kozuma, K. Tanabe, Y. Morino, Junya Ako, Shigeru Nakamura, K. Yamaji, S. Kohsaka, T. Amano, Yoshio Kobayashi, Y. Ikari, K. Kadota, M. Nakamura   +12 more
semanticscholar   +1 more source